Human interleukin-6

DB15060InvestigationalProtein Based Therapies

Human interleukin-6 is under investigation in clinical trial NCT03170245 (Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients).

Mechanism: Pharmacologically active on Interleukin-6 receptor subunit alpha
Curator reviewed
Also known as: HUMAN B-CELL STIMULATORY FACTOR 2 · HUMAN INTERFERON BETA-2 · IL-6 · IL6 · INTERFERON BETA-2 HUMAN

Resolves to

Compound

UNII4O4QWG0B3C

Clinical / RWD

RxNorm1367185

Targets

P08887IL6R

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Human interleukin-6, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account